Review



human leukemia carcinoma cell line  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    ATCC human leukemia carcinoma cell line
    Human Leukemia Carcinoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 998 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human leukemia carcinoma cell line/product/ATCC
    Average 96 stars, based on 998 article reviews
    human leukemia carcinoma cell line - by Bioz Stars, 2026-03
    96/100 stars

    Images



    Similar Products

    human leukemia carcinoma cell line  (ATCC)
    96
    ATCC human leukemia carcinoma cell line
    Human Leukemia Carcinoma Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human leukemia carcinoma cell line/product/ATCC
    Average 96 stars, based on 1 article reviews
    human leukemia carcinoma cell line - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier
    human leukemia carcinoma ccrf-cem cell line  (CEM Corporation)
    90
    CEM Corporation human leukemia carcinoma ccrf-cem cell line
    In vitro cytotoxicity of benzopyran-4-one-isoxazole conjugates (at a concentration of 25 μM) towards ( a ) human leukemia carcinoma (CCRF-CEM), ( b ) human ovarian <t>adenocarcinoma</t> (SKOV-3), ( c ) human breast tumor (MDA-MB-231), ( d ) human prostate cancer (PC-3), ( e ) androgen-independent human prostate cancer (DU-145), and ( f ) human renal carcinoma (iSLK) cell lines using DMSO and standard anticancer drug doxorubicin (Dox) (at a concentration of 5 μM) as controls after 24 and 72 h. The results are shown as the percentage of control that has no compound (set at 100%). All the experiments were performed in triplicate.
    Human Leukemia Carcinoma Ccrf Cem Cell Line, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human leukemia carcinoma ccrf-cem cell line/product/CEM Corporation
    Average 90 stars, based on 1 article reviews
    human leukemia carcinoma ccrf-cem cell line - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    human leukemia carcinoma cell lines  (CEM Corporation)
    90
    CEM Corporation human leukemia carcinoma cell lines
    In vitro cytotoxicity of benzopyran-4-one-isoxazole conjugates (at a concentration of 25 μM) towards ( a ) <t>human</t> <t>leukemia</t> carcinoma <t>(CCRF-CEM),</t> ( b ) human ovarian adenocarcinoma (SKOV-3), ( c ) human breast tumor (MDA-MB-231), ( d ) human prostate cancer (PC-3), ( e ) androgen-independent human prostate cancer (DU-145), and ( f ) human renal carcinoma (iSLK) cell lines using DMSO and standard anticancer drug doxorubicin (Dox) (at a concentration of 5 μM) as controls after 24 and 72 h. The results are shown as the percentage of control that has no compound (set at 100%). All the experiments were performed in triplicate.
    Human Leukemia Carcinoma Cell Lines, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human leukemia carcinoma cell lines/product/CEM Corporation
    Average 90 stars, based on 1 article reviews
    human leukemia carcinoma cell lines - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    human leukemia carcinoma cell line (ccrf-cem)  (CEM Corporation)
    90
    CEM Corporation human leukemia carcinoma cell line (ccrf-cem)
    In vitro cytotoxicity of benzopyran-4-one-isoxazole conjugates (at a concentration of 25 μM) towards ( a ) <t>human</t> <t>leukemia</t> carcinoma <t>(CCRF-CEM),</t> ( b ) human ovarian adenocarcinoma (SKOV-3), ( c ) human breast tumor (MDA-MB-231), ( d ) human prostate cancer (PC-3), ( e ) androgen-independent human prostate cancer (DU-145), and ( f ) human renal carcinoma (iSLK) cell lines using DMSO and standard anticancer drug doxorubicin (Dox) (at a concentration of 5 μM) as controls after 24 and 72 h. The results are shown as the percentage of control that has no compound (set at 100%). All the experiments were performed in triplicate.
    Human Leukemia Carcinoma Cell Line (Ccrf Cem), supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human leukemia carcinoma cell line (ccrf-cem)/product/CEM Corporation
    Average 90 stars, based on 1 article reviews
    human leukemia carcinoma cell line (ccrf-cem) - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    human leukemia carcinoma cell line  (CEM Corporation)
    90
    CEM Corporation human leukemia carcinoma cell line
    In vitro cytotoxicity of benzopyran-4-one-isoxazole conjugates (at a concentration of 25 μM) towards ( a ) <t>human</t> <t>leukemia</t> carcinoma <t>(CCRF-CEM),</t> ( b ) human ovarian adenocarcinoma (SKOV-3), ( c ) human breast tumor (MDA-MB-231), ( d ) human prostate cancer (PC-3), ( e ) androgen-independent human prostate cancer (DU-145), and ( f ) human renal carcinoma (iSLK) cell lines using DMSO and standard anticancer drug doxorubicin (Dox) (at a concentration of 5 μM) as controls after 24 and 72 h. The results are shown as the percentage of control that has no compound (set at 100%). All the experiments were performed in triplicate.
    Human Leukemia Carcinoma Cell Line, supplied by CEM Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human leukemia carcinoma cell line/product/CEM Corporation
    Average 90 stars, based on 1 article reviews
    human leukemia carcinoma cell line - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier
    human leukemia carcinoma cell line ccrf cem  (ATCC)
    96
    ATCC human leukemia carcinoma cell line ccrf cem
    In vitro cytotoxicity of benzopyran-4-one-isoxazole conjugates (at a concentration of 25 μM) towards ( a ) <t>human</t> <t>leukemia</t> carcinoma <t>(CCRF-CEM),</t> ( b ) human ovarian adenocarcinoma (SKOV-3), ( c ) human breast tumor (MDA-MB-231), ( d ) human prostate cancer (PC-3), ( e ) androgen-independent human prostate cancer (DU-145), and ( f ) human renal carcinoma (iSLK) cell lines using DMSO and standard anticancer drug doxorubicin (Dox) (at a concentration of 5 μM) as controls after 24 and 72 h. The results are shown as the percentage of control that has no compound (set at 100%). All the experiments were performed in triplicate.
    Human Leukemia Carcinoma Cell Line Ccrf Cem, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human leukemia carcinoma cell line ccrf cem/product/ATCC
    Average 96 stars, based on 1 article reviews
    human leukemia carcinoma cell line ccrf cem - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier
    human leukemia carcinoma cell line ccrfcem  (ATCC)
    96
    ATCC human leukemia carcinoma cell line ccrfcem
    In vitro cytotoxicity of benzopyran-4-one-isoxazole conjugates (at a concentration of 25 μM) towards ( a ) <t>human</t> <t>leukemia</t> carcinoma <t>(CCRF-CEM),</t> ( b ) human ovarian adenocarcinoma (SKOV-3), ( c ) human breast tumor (MDA-MB-231), ( d ) human prostate cancer (PC-3), ( e ) androgen-independent human prostate cancer (DU-145), and ( f ) human renal carcinoma (iSLK) cell lines using DMSO and standard anticancer drug doxorubicin (Dox) (at a concentration of 5 μM) as controls after 24 and 72 h. The results are shown as the percentage of control that has no compound (set at 100%). All the experiments were performed in triplicate.
    Human Leukemia Carcinoma Cell Line Ccrfcem, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human leukemia carcinoma cell line ccrfcem/product/ATCC
    Average 96 stars, based on 1 article reviews
    human leukemia carcinoma cell line ccrfcem - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier
    cell culture human leukemia carcinoma cell line ccrf cem  (ATCC)
    96
    ATCC cell culture human leukemia carcinoma cell line ccrf cem
    In vitro cytotoxicity of benzopyran-4-one-isoxazole conjugates (at a concentration of 25 μM) towards ( a ) <t>human</t> <t>leukemia</t> carcinoma <t>(CCRF-CEM),</t> ( b ) human ovarian adenocarcinoma (SKOV-3), ( c ) human breast tumor (MDA-MB-231), ( d ) human prostate cancer (PC-3), ( e ) androgen-independent human prostate cancer (DU-145), and ( f ) human renal carcinoma (iSLK) cell lines using DMSO and standard anticancer drug doxorubicin (Dox) (at a concentration of 5 μM) as controls after 24 and 72 h. The results are shown as the percentage of control that has no compound (set at 100%). All the experiments were performed in triplicate.
    Cell Culture Human Leukemia Carcinoma Cell Line Ccrf Cem, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cell culture human leukemia carcinoma cell line ccrf cem/product/ATCC
    Average 96 stars, based on 1 article reviews
    cell culture human leukemia carcinoma cell line ccrf cem - by Bioz Stars, 2026-03
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    In vitro cytotoxicity of benzopyran-4-one-isoxazole conjugates (at a concentration of 25 μM) towards ( a ) human leukemia carcinoma (CCRF-CEM), ( b ) human ovarian adenocarcinoma (SKOV-3), ( c ) human breast tumor (MDA-MB-231), ( d ) human prostate cancer (PC-3), ( e ) androgen-independent human prostate cancer (DU-145), and ( f ) human renal carcinoma (iSLK) cell lines using DMSO and standard anticancer drug doxorubicin (Dox) (at a concentration of 5 μM) as controls after 24 and 72 h. The results are shown as the percentage of control that has no compound (set at 100%). All the experiments were performed in triplicate.

    Journal: Molecules

    Article Title: Design, Synthesis, and Antiproliferative Activity of Benzopyran-4-One-Isoxazole Hybrid Compounds

    doi: 10.3390/molecules28104220

    Figure Lengend Snippet: In vitro cytotoxicity of benzopyran-4-one-isoxazole conjugates (at a concentration of 25 μM) towards ( a ) human leukemia carcinoma (CCRF-CEM), ( b ) human ovarian adenocarcinoma (SKOV-3), ( c ) human breast tumor (MDA-MB-231), ( d ) human prostate cancer (PC-3), ( e ) androgen-independent human prostate cancer (DU-145), and ( f ) human renal carcinoma (iSLK) cell lines using DMSO and standard anticancer drug doxorubicin (Dox) (at a concentration of 5 μM) as controls after 24 and 72 h. The results are shown as the percentage of control that has no compound (set at 100%). All the experiments were performed in triplicate.

    Article Snippet: This panel involved human leukemia carcinoma (CCRF-CEM), human ovarian adenocarcinoma (SKOV-3), human breast tumor (MDA-MB-231), human prostate cancer (PC-3), androgen-independent human prostate cancer (DU-145), and human renal carcinoma (iSLK) cell lines.

    Techniques: In Vitro, Concentration Assay, Control

    In vitro cytotoxicity of benzopyran-4-one-isoxazole conjugates (at a concentration of 25 μM) towards ( a ) human leukemia carcinoma (CCRF-CEM), ( b ) human ovarian adenocarcinoma (SKOV-3), ( c ) human breast tumor (MDA-MB-231), ( d ) human prostate cancer (PC-3), ( e ) androgen-independent human prostate cancer (DU-145), and ( f ) human renal carcinoma (iSLK) cell lines using DMSO and standard anticancer drug doxorubicin (Dox) (at a concentration of 5 μM) as controls after 24 and 72 h. The results are shown as the percentage of control that has no compound (set at 100%). All the experiments were performed in triplicate.

    Journal: Molecules

    Article Title: Design, Synthesis, and Antiproliferative Activity of Benzopyran-4-One-Isoxazole Hybrid Compounds

    doi: 10.3390/molecules28104220

    Figure Lengend Snippet: In vitro cytotoxicity of benzopyran-4-one-isoxazole conjugates (at a concentration of 25 μM) towards ( a ) human leukemia carcinoma (CCRF-CEM), ( b ) human ovarian adenocarcinoma (SKOV-3), ( c ) human breast tumor (MDA-MB-231), ( d ) human prostate cancer (PC-3), ( e ) androgen-independent human prostate cancer (DU-145), and ( f ) human renal carcinoma (iSLK) cell lines using DMSO and standard anticancer drug doxorubicin (Dox) (at a concentration of 5 μM) as controls after 24 and 72 h. The results are shown as the percentage of control that has no compound (set at 100%). All the experiments were performed in triplicate.

    Article Snippet: The in vitro cytotoxicity of the conjugates was evaluated using six human cancer cell lines, one human normal kidney cell line, and one mammalian normal kidney cell line, which included human leukemia carcinoma cell lines (CCRF-CEM), human ovarian adenocarcinoma cell lines (SKOV-3), human breast tumor cell lines (MDA-MB-231), human prostate cancer cell lines (PC-3), androgen-independent human prostate cancer cell lines (DU-145), human renal carcinoma (iSLK), human embryonic kidney cell lines (HEK-293), and normal mammalian kidney cell line (LLCPK) to determine the toxicity of the synthesized conjugates.

    Techniques: In Vitro, Concentration Assay, Control

    IC 50 (μM) of selected compounds 5a – d against human leukemia carcinoma (CCRF-CEM), human breast cancer (MDA-MB-231), human prostate cancer (PC-3), androgen-independent human prostate cancer (DU-145), and human embryonic kidney (HEK-293) cell lines.

    Journal: Molecules

    Article Title: Design, Synthesis, and Antiproliferative Activity of Benzopyran-4-One-Isoxazole Hybrid Compounds

    doi: 10.3390/molecules28104220

    Figure Lengend Snippet: IC 50 (μM) of selected compounds 5a – d against human leukemia carcinoma (CCRF-CEM), human breast cancer (MDA-MB-231), human prostate cancer (PC-3), androgen-independent human prostate cancer (DU-145), and human embryonic kidney (HEK-293) cell lines.

    Article Snippet: The in vitro cytotoxicity of the conjugates was evaluated using six human cancer cell lines, one human normal kidney cell line, and one mammalian normal kidney cell line, which included human leukemia carcinoma cell lines (CCRF-CEM), human ovarian adenocarcinoma cell lines (SKOV-3), human breast tumor cell lines (MDA-MB-231), human prostate cancer cell lines (PC-3), androgen-independent human prostate cancer cell lines (DU-145), human renal carcinoma (iSLK), human embryonic kidney cell lines (HEK-293), and normal mammalian kidney cell line (LLCPK) to determine the toxicity of the synthesized conjugates.

    Techniques: